Pharmaceutical / Drug Definition :
Thought to act as agonist at specific 5-HT1 receptor sites in intracranial vessels, causing vasoconstriction. Also may act on sensory trigeminal nerves, reducing transmission along pain pathways
FDA Label Requirements and Exceptions
Rizatriptan Benzoate
FDA Import Information
Rizatriptan Benzoate
FDA Detentions
Rizatriptan Benzoate (Rizatriptan Benzoate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Rizatriptan Benzoate (Rizatriptan Benzoate Suppliers)
- Processors Rizatriptan Benzoate
- Repackers Rizatriptan Benzoate
- Relabelers Rizatriptan Benzoate
- Exporters Rizatriptan Benzoate
- Importers Rizatriptan Benzoate
For more information about Rizatriptan Benzoate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
